ID: ALA4524751

Max Phase: Preclinical

Molecular Formula: C20H19N3O

Molecular Weight: 317.39

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CN(Cc1ccco1)c1nc2ccccc2n1Cc1ccccc1

Standard InChI:  InChI=1S/C20H19N3O/c1-22(15-17-10-7-13-24-17)20-21-18-11-5-6-12-19(18)23(20)14-16-8-3-2-4-9-16/h2-13H,14-15H2,1H3

Standard InChI Key:  DHVCGCMGWDOVIG-UHFFFAOYSA-N

Associated Targets(non-human)

Short transient receptor potential channel 5 64 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 317.39Molecular Weight (Monoisotopic): 317.1528AlogP: 4.31#Rotatable Bonds: 5
Polar Surface Area: 34.20Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 5.61CX LogP: 4.78CX LogD: 4.78
Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.55Np Likeness Score: -1.52

References

1. Sharma SH, Pablo JL, Montesinos MS, Greka A, Hopkins CR..  (2019)  Design, synthesis and characterization of novel N-heterocyclic-1-benzyl-1H-benzo[d]imidazole-2-amines as selective TRPC5 inhibitors leading to the identification of the selective compound, AC1903.,  29  (2): [PMID:30538066] [10.1016/j.bmcl.2018.12.007]

Source